Engineered Bacterial N-Demethylases for Paraxanthine Production

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There are limited natural resources for producing paraxanthine, and current chemically synthetic processes are costly and toxic, making it difficult to implement paraxanthine as a therapeutic due to high production costs.

Innovation Solution

Construct and screen Escherichia coli strains expressing N-demethylase mutant reductases with ndmA4, ndmD, and frmAB formaldehyde dehydrogenase genes to biocatalytically produce paraxanthine and 7-methylxanthine from caffeine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If chemically synthetic process is used to generate methylxanthines, then production can be achieved, but the process is toxic, costly, and not optimal for selective alkylation

Engineering Contradiction:

Improveproduction feasibilityVSAvoidtoxicity and cost

Core Design Contradiction:

Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical synthetic methods with a biocatalytic system using engineered bacteria (E. coli) that convert caffeine into paraxanthine and 7-methylxanthine through enzymatic reactions. This substitution eliminates the need for toxic chemicals and complex synthetic procedures while maintaining production capability.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent modifies the biological system by introducing specific gene expressions (ndmA4, ndmD, frmAB) into bacterial cells to control the biocatalytic conversion parameters. This allows optimization of selectivity, yield, and reaction conditions without the harmful effects of chemical synthesis.

Inventive Principle:

Principle #35Parameter changes

2Object-affected harmful factors

If biocatalysis is used to produce paraxanthine from caffeine, then cost-effectiveness and eco-friendliness are improved, but the process requires specific bacterial strain construction and gene expression

Engineering Contradiction:

Improveeco-friendliness and cost-effectivenessVSAvoidbacterial strain construction complexity

Core Design Contradiction:

Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent divides the biocatalytic system into functional components: the host bacterium (E. coli), the introduced genes (ndmA4, ndmD, frmAB), and the metabolic pathway. This segmentation allows independent optimization of each component while simplifying the overall system construction and troubleshooting.

Inventive Principle:

Principle #1Segmentation

3Quantity of substance

If natural resources are used to generate paraxanthine, then production can be sustained, but limited natural resources make it difficult to harvest at significant quantities

Engineering Contradiction:

Improveparaxanthine production quantityVSAvoidnatural resource availability

Core Design Contradiction:

Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The engineered bacteria utilize caffeine (a common metabolite in the human body) as their substrate and automatically produce paraxanthine and 7-methylxanthine through their metabolic pathway. The system is self-sufficient, requiring no external natural resources beyond the substrate, thereby overcoming the limitation of scarce natural sources.

Inventive Principle:

Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The biocatalytic process is cost-effective, eco-friendly, and operates at ambient temperatures, providing improved selectivity and efficiency in producing paraxanthine and 7-methylxanthine.

Implementation Method 1

contacting a bacterial strain expressing a N-demethylase mutant reductase with caffeine, theobromine, or theophylline

Methodology Applied

Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

there is a need to develop a biocatalysis to produce paraxanthine through biotransformation of caffeine

Methodology Applied

Scientific EffectBiotransformation: Fermentation

Implementation Method 3

the frmAB formaldehyde dehydrogenase genes

Methodology Applied

Scientific EffectOxidation: Oxidation

Data Source

PatentUS12448633B2Bacterial N-demthylases as biocatalysts for the production of methylxanthines

Publication Date: 2025.10.21 UNIVERSITY OF ALABAMA

AI summary

The present disclosure relates to mutant enzymes and bacterial strains constructed to produce paraxanthine and 7-methylxanthine from caffeine and methods for the manufacture and use thereof.